SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending amid ongoing discussions around U.S. efforts to secure the rare earth supply chain, with community members highlighting the stock's potential for upward recovery. Bullish sentiment centers on MP's existing government and Apple contracts, as well as potential tailwinds from trade negotiations and domestic mining initiatives. However, some traders express concern about market volatility and dependence on developments with China.

Superfruits AI is redefining the Web3 landscape with an ecosystem of fruit-themed AI agents offering specialized insights and services, ranging from blockchain security to market sentiment analysis. Building on this vibrant foundation, we're introducing groundbreaking features like a proprietary Web3-trained AI model, an interactive Virtual Research Room, and the innovative concept of "Juices." These "Juices" empower high token holders to mix and match agents' capabilities, creating custom virtual rooms where agents collaborate on tailored analyses for portfolios or projects. By blending cutting-edge AI with gamified user experiences, Superfruits AI positions itself as a pioneer in Web3 analytics, offering unique tools that not only secure but also enrich the decentralized journey for every user.

SuperFruits AI

SuperFruits AI ($SUPAI) is trending as the community discusses its potential breakout, highlighting the intersection of AI technology and market ambition. Discussions revolve around its strong chart structure, controlled volume, and the idea that it's forming a solid base for future growth. The community emphasizes a long-term vision, noting the presence of "smart money" and the building momentum behind the project.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a lawsuit filed by the company against a former FDA official for alleged bribery and defamation, sparking intense community discussion about potential stock manipulation and the fairness of the regulatory landscape.  Many are scrutinizing the FDA's handling of the situation and the potential impact on AUPH's drug approval prospects.  The stock's movement also comes amidst ongoing discussions about potential buyout scenarios and the company's pipeline.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

IWM is trending as small caps show renewed strength, potentially driven by hopes for easing trade tensions and upcoming Fed rate decisions, though some analysts caution about weakening breadth. Community members are actively discussing breakout levels and the potential for both bullish and bearish scenarios, as well as the impact of an expected Trump-Xi meeting. Fintwit debates whether this surge signals a broader market rally or if small caps are simply being manipulated.

Aurora is an EVM built on the NEAR Protocol, delivering a turn-key solution for developers to operate their apps on an Ethereum-compatible, high-throughput, scalable and future-safe platform, with low transaction costs for their users.

Aurora

Aurora is trending amid discussions of its connection to the NEAR Protocol and speculation about upcoming news, with community members weighing holding versus taking profits from recent price movement. Traders are actively watching for a breakout, drawing comparisons to past runs and mentioning potential targets. The coin's historical all-time high is also fueling speculation about future potential.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond is trending due to community interest around earnings, potential short squeezes, and strategic moves involving its Tzero platform. Discussions revolve around the company's financial health, recent partnerships, and the impact of key figures like Marcus Lemonis on its direction. Some traders are also eyeing potential confusion with similar tickers like $BYND.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana Inc. is trending as investors react to mixed sentiment surrounding the healthcare sector and Humana's specific challenges, including regulatory pressures impacting Medicare Advantage star ratings; recent reports suggest Humana may be partnering with Clover Health, spurring community interest. While some traders express frustration with perceived market manipulation and volatility, others see the dip as a buying opportunity, anticipating a future rebound and potential for long-term growth.

Rheinmetall AG is a holding company, which engages in the provision of development and sale of components, systems, and services for the security and civil industries. It operates through the following segments: Vehicle Systems, Weapon and Ammunition, Electronic Solutions, Sensors and Actuators, Materials and Trade, and Others. The Vehicle Systems segment offers a diverse portfolio of vehicles, including combat, support, logistics, and special vehicles. The Weapon and Ammunition segment includes products and solutions for threat-appropriate, firepower as well as comprehensive protection. The Electronic Solutions segment is involved in the chain of effects in the system network, from sensors and the networking of platforms and soldiers to the automated connection of effectors, as well as solutions for protection in cyberspace. The Sensors and Actuators consists of a product portfolio with exhaust gas recirculation systems, throttle valves, control dampers, and exhaust flaps for electromotors, solenoid valves, actuators and valve train systems, oil, water, and vacuum pumps for passenger cars, commercial vehicles, and light and heavy-duty off-road applications, as well as industrial solutions. The Materials and Trade segment focuses on the development of system components for the basic motor. The company was founded by Heinrich Ehrhardt on April 13, 1889 and is headquartered in Duesseldorf, Germany.

Rheinmetall AG - ADR

Rheinmetall (RNMBY) is trending amid discussions around increased defense spending and its potential role in European rearmament, particularly with ongoing geopolitical tensions and conflicts. Community chatter includes potential benefits from new contracts, expansion plans, and comparisons to other high-growth stocks, with some highlighting insider trading and future growth.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

USO is trending as OPEC+ considers further output hikes, sparking concerns about oversupply amid signs of weakening demand and increasing US oil production. Community members are closely watching potential downside risks as renewable energy projects expand and alternative energy sources gain traction. Geopolitical tensions and production decisions continue to influence the price action of USO.

ProShares Trust - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is trending due to fluctuating oil prices influenced by OPEC+ decisions, geopolitical tensions, and discussions around increasing or pausing output. Community members are weighing the impact of potential oversupply and global demand concerns, while also monitoring options activity and potential ROI from UCO calls. The ongoing energy transition and alternative energy sources add further context to the conversation around crude oil's future.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rigel Gears Up to Report Q3 Earnings: Here's What to Expect

RIGL's rising Tavalisse sales, along with incremental sales from Rezlidhia and Gavreto, could power another earnings beat in the quarter to be reported.

Coupang Set to Report Q3 Earnings: What's in Store for the Stock?

CPNG sees momentum in Taiwan and logistics ahead of Q3 results, while investments may weigh on margins.

Arcutis Biotherapeutics, Inc. (ARQT) Hits Fresh High: Is There Still Room to Run?

Arcutis Biotherapeutics (ARQT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect

ZTS is poised for another earnings beat as rising demand for companion animal products like Simparica Trio and Apoquel drives expected Q3 revenue growth.

TEM vs. EXAS: Which Genomics Player Offers Greater Upside?

Tempus AI's soaring genomics revenues and Exact Sciences' diagnostic breakthroughs spotlight two distinct routes to precision oncology growth.

Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

Strong Trikafta/Kaftrio demand, along with contributions from Alyftrek, Casgevy and Journavx, may have helped VRTX outperform in the third quarter.

Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth

Exelixis (EXEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Avidity Biosciences (RNA) Moves 42.4% Higher: Will This Strength Last?

Avidity Biosciences (RNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards?

ANIP's rising Cortrophin Gel sales and new rare disease products, along with generic and other segments, could power another earnings beat this quarter.

Exact Sciences (EXAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Exact Sciences Corp.

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$64.69
Prev Close	$63.22
Open	$63.22
Dividend Yield	0.00%
50-Day Moving Average	$55.96
Beta	1.01
Avg. Volume	2.71M
PE Ratio	-11.93

52-Week High	$72.83
52-Week Low	$38.81
Market Capitalization	$12.25B
EPS (Annual)	-$5.59
Price to Book	4.96
Revenue Per Employee	$394,123.86
Enterprise Value/EBITDA	N/A

EXAS
Exact Sciences Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EXAS News

EXASExact Sciences Corp.